SEARCH

SEARCH BY CITATION

References

  • Antequera F. and Bird A. (1993) Number of CpG islands and genes in human and mouse. Proc. Natl Acad. Sci. USA 90, 11 99511 999.
  • Baron M. K., Boeckers T. M., Vaida B., Faham S., Gingery M., Sawaya M. R., Salyer D., Gundelfinger E. D. and Bowie J. U. (2006) An architectural framework that may lie at the core of the postsynaptic density. Science 311, 531535.
  • Bird A., Taggart M., Frommer M., Miller O. J. and Macleod D. (1985) A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40, 9199.
  • Bockers T. M., Mameza M. G., Kreutz M. R., Bockmann J., Weise C., Buck F., Richter D., Gundelfinger E. D. and Kreienkamp H. J. (2001) Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin. J. Biol. Chem. 276, 40 10440 112.
  • Boeckers T. M., Winter C., Smalla K. H., Kreutz M. R., Bockmann J., Seidenbecher C., Garner C. C. and Gundelfinger E. D. (1999a) Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem. Biophys. Res. Commun. 264, 247252.
  • Boeckers T. M., Kreutz M. R., Winter C. et al. (1999b) Proline-rich synapse-associated protein-1/cortactin binding protein 1 (ProSAP1/CortBP1) is a PDZ-domain protein highly enriched in the postsynaptic density. J. Neurosci. 19, 65066518.
  • Bonaglia M. C., Giorda R., Borgatti R., Felisari G., Gagliardi C., Selicorni A. and Zuffardi O. (2001) Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261268.
  • Bonaglia M. C., Giorda R., Mani E., Aceti G., Anderlid B. M., Baroncini A., Pramparo T. and Zuffardi O. (2006) Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J. Med. Genet. 43, 822828.
  • Brewer G. J., Torricelli J. R., Evege E. K. and Price P. J. (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567576.
  • Ching T. T., Maunakea A. K., Jun P. et al. (2005) Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nat. Genet. 37, 645651.
  • De Smet C., Lurquin C., Lethe B., Martelange V. and Boon T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell Biol. 19, 73277335.
  • Dekker J., Rippe K., Dekker M. and Kleckner N. (2002) Capturing chromosome conformation. Science 295, 13061311.
  • Du Y., Weed S. A., Xiong W.-C., Marshall T. D. and Parsons J. T. (1998) Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol. Cell Biol. 18, 58385851.
  • Fuks F., Hurd P. J., Wolf D., Nan X., Bird A. P. and Kouzarides T. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278, 40354040.
  • Gardiner-Garden M. and Frommer M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261282.
  • Gitan R. S., Shi H., Chen C. M., Yan P. S. and Huang T. H. (2002) Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res. 12, 158164.
  • Grunau C., Clark S. J. and Rosenthal A. (2001) Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 29, E6565.
  • Havens J. M., Visootsak J., Phelan M. C., and Graham J. M. Jr (2004) 22q13 deletion syndrome: an update and review for the primary pediatrician. Clin. Pediatr. (Phila.) 43, 4353.
  • Horike S., Cai S., Miyano M., Cheng J. F. and Kohwi-Shigematsu T. (2005) Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37, 3140.
  • Kimura H. and Shiota K. (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem. 278, 48064812.
  • Kubota T., Das S., Christian S. L., Baylin S. B., Herman J. G. and Ledbetter D. H. (1997) Methylation-specific PCR simplifies imprinting analysis. Nat. Genet. 16, 1617.
  • Larsen F., Gundersen G., Lopez R. and Prydz H. (1992) CpG islands as gene markers in the human genome. Genomics 13, 10951107.
  • Lim S., Naisbitt S., Yoon J., Hwang J. I., Suh P. G., Sheng M. and Kim E. (1999) Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J. Biol. Chem. 274, 29 51029 518.
  • Lorincz M. C., Dickerson D. R., Schmitt M. and Groudine M. (2004) Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat. Struct. Mol. Biol. 11, 10681075.
  • Lunyak V. V., Burgess R., Prefontaine G. G. et al. (2002) Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298, 17471752.
  • Makedonski K., Abuhatzira L., Kaufman Y., Razin A. and Shemer R. (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum. Mol. Genet. 14, 10491058.
  • Matsuyama T., Kimura M. T., Koike K., Abe T., Nakano T., Asami T., Ebisuzaki T., Held W. A., Yoshida S. and Nagase H. (2003) Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: applications of virtual image restriction landmark genomic scanning (Vi-RLGS). Nucleic Acids Res. 31, 44904496.
  • McWilliams R. R., Gidey E., Fouassier L., Weed S. A. and Doctor R. B. (2004) Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells. Biochem. J. 380, 181191.
  • Naisbitt S., Kim E., Tu J. C., Xiao B., Sala C., Valtschanoff J., Weinberg R. J., Worley P. F. and Sheng M. (1999) Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23, 569582.
  • Noh J. S., Sharma R. P., Veldic M., Salvacion A. A., Jia X., Chen Y., Costa E., Guidotti A. and Grayson D. R. (2005) DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc. Natl Acad. Sci. USA 102, 17491754.
  • Novik K. L., Nimmrich I., Genc B., Maier S., Piepenbrock C., Olek A. and Beck S. (2002) Epigenomics: genome-wide study of methylation phenomena. Curr. Issues Mol. Biol. 4, 111128.
  • Phelan M. C., Rogers R. C., Saul R. A., Stapleton G. A., Sweet K., McDermid H., Shaw S. R., Claytor J., Willis J. and Kelly D. P. (2001) 22q13 deletion syndrome. Am. J. Med. Genet. 101, 9199.
  • Redecker P., Gundelfinger E. D. and Boeckers T. M. (2001) The cortactin-binding postsynaptic density protein proSAP1 in non-neuronal cells. J. Histochem. Cytochem. 49, 639648.
  • Robinson P. N., Bohme U., Lopez R., Mundlos S. and Nurnberg P. (2004) Gene-Ontology analysis reveals association of tissue-specific 5′ CpG-island genes with development and embryogenesis. Hum. Mol. Genet. 13, 19691978.
  • Roussignol G., Ango F., Romorini S., Tu J. C., Sala C., Worley P. F., Bockaert J. and Fagni L. (2005) Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 25, 35603570.
  • Sala C., Piech V., Wilson N. R., Passafaro M., Liu G. and Sheng M. (2001) Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31, 115130.
  • Sala C., Futai K., Yamamoto K., Worley P. F., Hayashi Y. and Sheng M. (2003) Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a. J. Neurosci. 23, 63276337.
  • Sala C., Roussignol C., Meldolesi J. and Fagni L. (2005) Key role of the postsynaptic density scaffold proteins Shank and Homer in the functional architecture of Ca2+ homeostasis at dendritic spines in hippocampal neurons. J. Neurosci. 25, 45874592.
  • Samaco R. C., Hogart A. and LaSalle J. M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483492.
  • Shi H., Maier S., Nimmrich I., Yan P. S., Caldwell C. W., Olek A. and Huang T. H. (2003) Oligonucleotide-based microarray for DNA methylation analysis: principles and applications. J. Cell Biochem. 88, 138143.
  • Song F., Smith J. F., Kimura M. T., Morrow A. D., Matsuyama T., Nagase H. and Held W. A. (2005) Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl Acad. Sci. USA 102, 33363341.
  • Surani M. A. (1998) Imprinting and the initiation of gene silencing in the germ line. Cell 93, 309312.
  • Takai D. and Jones P. A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA 99, 37403745.
  • Thatcher K. N., Peddada S., Yasui D. H. and Lasalle J. M. (2005) Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples. Hum. Mol. Genet. 14, 785797.
  • Tolhuis B., Palstra R. J., Splinter E., Grosveld F. and De Laat W. (2002) Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10, 14531465.
  • Uchino S., Wada H., Honda S., Nakamura Y., Oudo Y., Uchiyama T., Tsutsumi M., Suzuki E., Hirasawa T. and Kohsaka S. (2006) Direct interaction of post-synaptic density-95/Dlg/ZO-1 domain-containing synaptic molecule Shank 3 with Glu R1 alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor. J. Neurochem. 97, 12031214.
  • Wilson H. L., Wong A. C., Shaw S. R., Tse W. Y., Stapleton G. A., Phelan M. C., Hu S., Marshall J. and McDermid H. E. (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575584.
  • Zhang Z., Chen C. Q. and Manev H. (2004) DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: evidence in human NT2 and NT2-N cells. J. Neurochem. 88, 14241430.